Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
News
Nature Biotechnology 27, 967 (1 November 2009) | doi:10.1038/nbt1109-967a
One shot at H1N1
Abstract
A single injection of unadjuvanted vaccine could provide adequate immunity to protect most people during the expected influenza A (H1N1) pandemic, an early study suggests. The findings published in September (N.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
